Novel dual inhibitors of calpain and lipid peroxidation

被引：20

作者：

Auvin, S

Pignol, B

Navet, E

Pons, D

Marin, JG

Bigg, D

Chabrier, PE

机构：

[1] Inst Henri Beaufour, Ipsen Res Labs, Dept Med Chem, F-91966 Les Ulis, France

[2] Inst Henri Beaufour, Ipsen Res Labs, Dept Neurobiol, F-91966 Les Ulis, France

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 14期

关键词：

calpain inhibition; antioxidants;

D O I：

10.1016/j.bmcl.2004.04.105

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of molecules with dual inhibitory activities on calpain and lipid peroxidation were synthesized. These hybrid compounds were built on the calpain pharmacophore 2-hydroxytetrahydrofuran linked to a set of antioxidants via a L-leucine linker. Compound 7, the most potent in cellular calpain and lipid peroxidation inhibitions, provided effective protection against glial cell death induced by maitotoxin. (C) 2004 Elsevier Ltd. All rights reserved.

引用

收藏

页码：3825 / 3828

页数：4

相关论文

共 15 条

[1] BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation:: A promising neuroprotective strategy [J].

Chabrier, PE ;

Auguet, M ;

Spinnewyn, B ;

Auvin, S ;

Cornet, S ;

Demerlé-Pallardy, C ;

Guilmard-Favre, C ;

Marin, JG ;

Pignol, B ;

Gillard-Roubert, V ;

Roussillot-Charnet, C ;

Schulz, J ;

Viossat, I ;

Bigg, D ;

Moncada, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (19) :10824-10829

[2]

CHABRIER PE, 2002, Patent No. 0240016

[3] Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs [J].

Chan, C ;

Yin, H ;

Garforth, J ;

McKie, JH ;

Jaouhari, R ;

Speers, P ;

Douglas, KT ;

Rock, PJ ;

Yardley, V ;

Croft, SL ;

Fairlamb, AH .

JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (02) :148-156

[4] CHEMISTRY AND BIOCHEMISTRY OF 4-HYDROXYNONENAL, MALONALDEHYDE AND RELATED ALDEHYDES [J].

ESTERBAUER, H ;

SCHAUR, RJ ;

ZOLLNER, H .

FREE RADICAL BIOLOGY AND MEDICINE, 1991, 11 (01) :81-128

[5] Subsite requirements for peptide aldehyde inhibitors of human calpain I [J].

Iqbal, M ;

Messina, PA ;

Freed, B ;

Das, M ;

Chatterjee, S ;

Tripathy, R ;

Tao, M ;

Josef, KA ;

Dembofsky, B ;

Dunn, D ;

Griffith, E ;

Siman, R ;

Senadhi, SE ;

Biazzo, W ;

BozyczkoCoyne, D ;

Meyer, SL ;

Ator, MA ;

Bihovsky, R .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (05) :539-544

[6]

ISAAC OD, 2000, CURR MED CHEM, V7, P1171

[7]

KATRITZKY AR, 1988, SYNTHESIS-STUTTGART, P215

[8] Alterations of extracellular calcium elicit selective modes of cell death and protease activation in SH-SY5Y human neuroblastoma cells [J].

McGinnis, KM ;

Wang, KKW ;

Gnegy, ME .

JOURNAL OF NEUROCHEMISTRY, 1999, 72 (05) :1853-1863

[9] Biologically active monomeric and heterodimeric recombinant human calpain I produced using the baculovirus expression system [J].

Meyer, SL ;

BozyczkoCoyne, D ;

Mallya, SK ;

Spais, CM ;

Bihovsky, R ;

Kawooya, JK ;

Lang, DM ;

Scott, RW ;

Siman, R .

BIOCHEMICAL JOURNAL, 1996, 314 :511-519

[10] Exploration of cornea permeable calpain inhibitors as anticataract agents [J].

Nakamura, M ;

Yamaguchi, M ;

Sakai, O ;

Inoue, J .

BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (07) :1371-1379